Will Canopy Growth (TSX:WEED) Stock Bring Investors Cheer in the New Year?

Canopy Growth (TSX:WEED)(NYSE:CGC) stock is much cheaper than it was earlier this year. Should you buy now?

| More on:
Adult family preparing dinner on Christmas Day

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Marijuana stocks had a wild ride in 2019, and investors are wondering if pot stocks can shake off the hangover in 2020 and deliver big returns for investors.

Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) to see if it deserves to be on your contrarian buy list for 2020.

Volatile year

Canopy Growth’s stock price started 2019 near $40 per share. It rallied as high as $70 in the spring and recently dipped below $20.

The share prices of all the Canadian cannabis stocks have had a crazy 12 months, primarily due to an unimpressive launch of the recreational cannabis market. Investors had high hopes for robust revenue and clear paths to profitability when recreational sales became legal in late 2018.

Unfortunately, the pot producers and their distribution networks weren’t quite ready when the gun went off. Rather than sprinting to a great start, the sector stumbled out of the blocks.

Supply problems went from a lack of product to oversupplied in 2019 amid lacklustre sales after the initial hype. Companies misjudged the potential popularity of some cannabis products, and overstock issues have resulted in large quantities of unsold items being returned or, in some cases, discounted heavily to clear them out.

An absence of physical retail locations in key markets, such as Ontario and Quebec, also had an impact.

Company-specific challenges hurt the industry as well. Accusations of self-dealing and the discovery of unlicensed production indicated the sector was, in some cases, taking a wild-west approach. This hasn’t gone over well with government authorities, who have tightened up regulations.

Vastly over-inflated revenue projections have also tainted the credibility of some management teams.

Investors, as a result, have stepped back while all the dust settles. Sky-high valuations are only sustainable if the market continues to believe that anticipated revenue growth will occur. As we saw in the second half of 2019, investors hit the reset button.

Canopy Growth is arguably the leader in the cannabis industry, but it too has had some issues. Revenue stalled out this year, while expenses continued to soar. In early July, the board fired the company’s founding CEO and chairman.

You might ask how that could happen, but Canopy Growth’s largest shareholder, Constellation Brands, started to become uncomfortable with the rising losses and decided there needed to be a leadership change. Constellation initially put its CFO in the chairman role and then decided to make him the new CEO.

Canopy Growth had a war chest of cash to spend after Constellation Brands invested $5 billion in the summer of 2018 at more than $48 per share. It started to deploy it on strategic acquisitions and setting up operations around the world to tap potential new markets, as governments adjust their marijuana regulations.

Pundits suggest Constellation Brands wanted to slow down the pace a bit and set a plan for reaching profitability.

Should you buy Canopy Growth?

Ongoing volatility should be expected, so I wouldn’t back up the truck.

However, investors who are positive on the long-term potential for the sector should probably have Canopy Growth in their portfolios. The stock isn’t cheap, but it is more attractive than it was earlier in the year, and any good news could bring a wave of new buyers in 2020 to push the share price higher.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Constellation Brands. Fool contributor Andrew Walker has no position in any stock mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »